Assisting HIV-infected Mothers in Disclosing Their Serostatus to Their Children (TRACK)

University of California, Los Angeles (UCLA)

Status and phase: Completed; Phase 1

Conditions: HIV

Treatments: Behavioral: Teaching, Raising, and Communicating with Kids (TRACK); Other: Treatment as usual

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00429546

DAHBR 9A-ASAP

R01MH077493 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study will develop and evaluate the effectiveness of an intervention designed to assist HIV-infected mothers of young children in determining whether and how to appropriately disclose their HIV serostatus to their children.

Full description

HIV is a serious, life threatening illness that requires a lifetime of treatment and disease management. Studies have shown that it can be very difficult for infected mothers to decide whether and/or when to disclose their HIV serostatus to their uninfected children. HIV-infected parents struggle with the fear that their children will be forced to grow up too quickly, become worried or depressed, or be angry with their parents once they learn that their parents have HIV. Family-based intervention programs have been successful in helping facilitate the disclosure process. This study will develop and evaluate the effectiveness of an intervention designed to assist HIV-infected mothers of young children in determining whether and how to appropriately disclose their HIV serostatus to their children.

Participants in this study will be randomly assigned to either the intervention or a standard of care condition. The intervention will consist of three 75-minute sessions that will focus on exploring mothers' concerns, determining children's readiness to receive the news, planning for disclosure, and practicing disclosure. Participants will also receive one follow-up phone call from the therapist about 3 weeks after the last session. Sessions will be scheduled at times that are convenient for the participants and therapists. Follow-up visits will include both mothers and their children, and will be held at Months 3, 6, and 9 following the end of the intervention. Assessments will include readiness to disclose HIV serostatus, mental health indicators, and family functioning.

Enrollment: 160 patients

Sex: All

Ages: 6 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Confirmation of mother's HIV/AIDS status
• Healthy child (i.e., HIV uninfected) who is between 6 and 12 years of age and is unaware of maternal serostatus
• Mother is primary caregiver and child resides with her
• English- or Spanish-speaking

Exclusion criteria

• Child does not meet screening criteria (e.g., diagnosed with depression or suicide attempt, IQ score less than 75)
• Psychosis of parent or child (as advised by recruitment site clinicians)
• Child refuses to give assent

Trial design

160 participants in 2 patient groups

Intervention

Experimental group

Description:

Participants will receive a cognitive-behavioral intervention designed to improve mother-child communication and parenting skills and prepare caregiver for disclosure of HIV serostatus to child

Treatment:

Behavioral: Teaching, Raising, and Communicating with Kids (TRACK)

Control

Active Comparator group

Description:

Participants will receive treatment as usual

Treatment:

Other: Treatment as usual